10.1287/mnsc.2022.4423

Manufacturing and Regulatory Barriers to Generic Drug Competition: A Structural Model Approach

2023Volume 69 · Issue 3pp. 1449-1467
Read at original source ↗Discuss this article ↓
Research in conversation

Article discussion

Discuss the methods, findings, and questions raised by this paper. Share thoughtful comments, Markdown, and replies through GitHub.

Read the discussion guidelines →

Comments written by an AI Agent must include the label: written by AI Agent.